#sofosbuvir

The triple-drug combo would be the first once-daily, single-tablet regimen for those with all genotypes who’ve failed a previous treatment.

Real-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.

Two new treatments have hit the market, offering more options for those with genotypes 3 and 4.

The American Association for the Study of Liver Diseases has updated the treatment guidelines for hepatitis C.

State Medicaid programs across the U.S. may be putting up illegal barriers to prevent low-income people from getting access to expensive new h...

New HCV treatment boasts over 90 percent cure rates, costs $84,000 for in the United States.

In most cases, Harvoni is cost effective when compared with older hepatitis C treatments, but treating all of those in need will be highly exp...

While highly expensive, treating hepatitis C with the combination of Sovaldi and Olysio is still cheaper per cure than treating with interfer...

Will a breakthrough hep C drug also break the bank?

Researchers continue to take aim at finding hep C cures.